A Short Peptide Inhibitor as an Activity-Based Probe for Matriptase-2.

about

A Short Peptide Inhibitor as an Activity-Based Probe for Matriptase-2.

Item

http://www.wikidata.org/entity/Q55643810

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

A Short Peptide Inhibitor as an Activity-Based Probe for Matriptase-2.

@en

A Short Peptide Inhibitor as an Activity-Based Probe for Matriptase-2.

@nl

type

Item

label

A Short Peptide Inhibitor as an Activity-Based Probe for Matriptase-2.

@en

A Short Peptide Inhibitor as an Activity-Based Probe for Matriptase-2.

@nl

prefLabel

A Short Peptide Inhibitor as an Activity-Based Probe for Matriptase-2.

@en

A Short Peptide Inhibitor as an Activity-Based Probe for Matriptase-2.

@nl

P1476

A Short Peptide Inhibitor as an Activity-Based Probe for Matriptase-2

@en

P2093

Marit Stirnberg

http://www.w3.org/2001/XMLSchema#string

Martin Mangold

http://www.w3.org/2001/XMLSchema#string

P2860

Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)

Modulation of hepcidin as therapy for primary and secondary iron overload disorders: preclinical models and approaches

The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin

The serine protease TMPRSS6 is required to sense iron deficiency

Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis

Substrate specificity of human matriptase-2.

Detection of active matriptase using a biotinylated chloromethyl ketone peptide

Aprotinin: a serine protease inhibitor with therapeutic actions: its interaction with ACE inhibitors.

P31

scholarly article

P356

10.3390/PH11020049

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Gütschow

P577

2018-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29883401

http://www.w3.org/2001/XMLSchema#string

P932

6027297

http://www.w3.org/2001/XMLSchema#string